Physician

Donald C Haas, MD

According to 2025 Medicare claims, Donald Haas, MD (NPI: 1205876406) practices advanced heart failure and transplant cardiology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is ABINGTON MEMORIAL HOSPITAL (NPI: 1871628024; TIN: 231352152) and primary practice location at 19001-3720. Haas is affiliated with the Delaware Valley ACO (ACO ID: A2024), participating under the MSSP model.

Haas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 229 traditional Medicare patients, billed 877 HCPCS/CPT codes, and received $70,516 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,812 prescription claims across 263 beneficiaries totaling $7,086,975 in drug costs, led by Vyndamax (Tafamidis). DME data shows 713 claims. Open Payments data shows 24 records totaling $136,568. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $63,519 to $7,086,975. For DME billing, reported payments rose steadily, from $26,472 to $52,393.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	206	1,507	$122,177
2016	212	1,469	$112,617
2017	193	1,200	$89,153
2018	214	1,611	$120,839
2019	223	1,499	$118,921
2020	198	1,438	$117,260
2021	235	1,460	$122,427
2022	251	1,356	$111,578
2023	264	1,347	$107,850
2024	229	877	$70,516

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	110	961	$63,519
2016	136	1,187	$100,382
2017	171	1,305	$158,210
2018	161	1,322	$301,734
2019	173	1,441	$372,798
2020	173	1,701	$262,367
2021	209	1,571	$1,098,725
2022	230	1,748	$3,180,019
2023	271	1,898	$4,858,252
2024	263	1,812	$7,086,975

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	32	$1,750
2016	N/R	47	$34,332
2017	N/R	11	$2,584
2018	51	406	$67,863
2019	N/R	577	$57,275
2020	N/R	511	$54,716
2021	49	893	$108,910
2022	59	1,080	$116,901
2023	77	832	$67,770
2024	22	713	$66,994

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	52	78	$135
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	79	110	$98
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	37	78	$95
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	105	147	$70
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	48	116	$63

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyndamax	Tafamidis	249	7,800	$5,803,275
Wainua	Eplontersen Sodium	11	308	$462,197
Camzyos	Mavacamten	22	660	$183,305
Opsumit	Macitentan	13	390	$166,974
Entresto	Sacubitril/Valsartan	88	5,400	$115,969

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	11	220	$39,776
J2260	Injection, milrinone lactate, 5 mg	N	N/R	197	$13,099
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	36	$6,878
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	11	211	$4,009
J1250	Injection, dobutamine hydrochloride, per 250 mg	N	N/R	23	$2,841

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$4,571	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	11	$131,996	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Donald C. Haas, MD?

Tedicare shows public-source Medicare data for Donald C. Haas, MD (NPI 1205876406), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Donald C. Haas, MD have ACO affiliation data?

Donald C. Haas, MD is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024).

What billing organization is linked to Donald C. Haas, MD?

Donald C. Haas, MD is linked to ABINGTON MEMORIAL HOSPITAL (billing NPI 1871628024) in the available physician profile data.

Does Donald C. Haas, MD have Open Payments data?

Donald C. Haas, MD has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.